Posts Tagged "Stephan Schurer"



A new version of the LIFE search engine has been released. LIFE makes it possible to search across data generated at the LINCS project.  This new release includes recent data releases from the LINCS Consortium. It has improved search functionality and several new data visualization features. LIFE is developed at the University of Miami LINCS Center under leadership of CCS Drug Discovery Program Director Dr. Stephan Schürer.  More...

Read More
CDD and CCS receive NIH SBIR Award

Collaborative Drug Discovery (CDD) and researchers at the Center for Computational Science of the University of Miami received a National Institutes of Health (NIH) (Small Business Innovation Research) SBIR Award to develop novel assay annotation technology for the CDD Vault leveraging our BioAssay Ontology (BAO).  The project leads at UM are Dr. Stephan Schurer, Lead Cheminformatics Scientist at CCS and Dr. Ubbo Visser, Associate...

Read More
Researchers to Create World Database at CCS for Nervous System Repair

With the ultimate goal of accelerating the discovery of drugs to regenerate or protect nerves after spinal cord injury, UM Miller School researchers have received a $2.5 million grant to develop a novel database via the Center for Computational Science to enable neuroscientists to search the voluminous and growing number of studies related to nervous system repair, and link relevant data from those studies to other resources. “Right...

Read More
NIH funds “LIFE”

Congratulations to Drs. Stephan Schurer, Vance Lemmon, Ubbo Visser, and the Cheminformatics Group, recipients of  NIH funding for their proposal entitled "LINCS Information FramEwork (LIFE) to Integrate and Analyze Diverse Data set". This project proposes to develop a novel information system that will help scientists to access and use information generated by the NIH LINCS project and other public data sources. Abstract The LINCS...

Read More
New Publication in NATURE

Anti-diabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation Researchers from the Center for Computational Science (CCS) with their collaborators from Harvard, The Scripps Research Institute, and Yale have just published a study, "Anti-diabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation" in the prestigious journal Nature that may lead to the development of novel, safer,...

Read More
CCS
Skip to toolbar